Benjamin Weide

11.8k citations
74 papers · 3.6k indexed · 1 hit paper · h-index 29
  • Immunology top 1%
    • Immunotherapy and Immune Responses 27
    • Immune Cell Function and Interaction 8
  • Oncology top 1%
    • Cancer Immunotherapy and Biomarkers 24
    • Cutaneous Melanoma Detection and Management 19
    • CAR-T cell therapy research 19
    • Melanoma and MAPK Pathways 17
    • RNA Interference and Gene Delivery 5
    • Nonmelanoma Skin Cancer Studies 6

Benjamin Weide

73 papers receiving 3.6k citations

Hit Papers

Ipilimumab-dependent cell-mediated cytotoxicity of regula...4602015202620182022100200300400

Peers

Benjamin Weide
Comparison fields: 5 of 97
  • Immunology 2.0k
  • Oncology 2.1k
  • Molecular Biology 1.4k
  • Dermatology 176
  • Cancer Research 216
Replace Ryan Emerson with:
Ryan Emerson United States
Maria Pia Protti Italy
Laura Bover United States
Joshua Brody United States
Erik Hooijberg Netherlands
Kevin Gorski United States
Thomas Brocker Germany
Frank J. Hsu United States
Debra K. Czerwinski United States
Neil L. Berinstein Canada
Benjamin Weide relative to Ryan Emerson United States Ryan Emerson's profile →
Citations per field
00.5×1.5×
Ryan Emerson · 1×
Citations per year

Countries citing papers authored by Benjamin Weide

Since Specialization
Citations

This map shows the geographic impact of Benjamin Weide's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin Weide with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin Weide more than expected).

Fields of papers citing papers by Benjamin Weide

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Benjamin Weide. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin Weide. The network helps show where Benjamin Weide may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Benjamin Weide, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Benjamin Weide Line = papers co-authored together Benjamin Weide links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 202111
2 20207
3 201941
4 201713
5 201730
6 201717
7 2016141
8 201627
9 201510
10 201477
11 201435
12 20144
13 201416
14 2013210
15 201323
16 201352
17 201219
18 2011125
19 201140
20 201017

About Benjamin Weide

Benjamin Weide is a scholar working on Oncology, Immunology and Dermatology, having authored 74 papers that have together received 3.6k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (27 papers), Cancer Immunotherapy and Biomarkers (24 papers), Cutaneous Melanoma Detection and Management (19 papers), CAR-T cell therapy research (19 papers), Melanoma and MAPK Pathways (17 papers), Immune Cell Function and Interaction (8 papers), Nonmelanoma Skin Cancer Studies (6 papers) and RNA Interference and Gene Delivery (5 papers). The work is most often cited by research in Immunology (2.0k citations), Oncology (2.1k citations) and Molecular Biology (1.4k citations). Benjamin Weide has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Claus Garbe, Thomas Eigentler, Graham Pawelec, Steve Pascolo, Annette Pflugfelder, Birgit Scheel, Ingmar Hoerr, Hans‐Georg Rammensee, Evelyna Derhovanessian and Henning Zelba. Their work appears in journals such as Cancer Immunology Immunotherapy, Journal of Clinical Oncology, PLoS ONE, Clinical Cancer Research and British Journal of Dermatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026